Pharmacy Times
NOVEMBER 23, 2024
Intravenous immunoglobulin (IVIG) has proven efficacy in autoimmune neuropathies, with mixed but promising outcomes in severe COVID-19 cases and post-acute sequelae of SARS-CoV-2 infection trials.
Scott Burrows
NOVEMBER 23, 2024
Healthcare professionals work in one of the most demanding, high-stakes environments. The hours are long, the emotional toll is high, and the pressure to provide the best care for every patient can sometimes feel overwhelming. It’s no surprise, then, that burnout has become an all-too-common challenge in the healthcare industry. But here’s the good news: your mindset is one of the most powerful tools you have to combat burnout, reduce stress, and keep yourself thriving in your profession.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaTech
NOVEMBER 23, 2024
FDA's approval will allow Kedrion to manufacture Ryplazim (plasminogen, human-tvmh), the only FDA-approved therapy for treating PLGD-1, at facility in Bolognana, Italy.
Pharmacy Times
NOVEMBER 23, 2024
Belantamab mafodotin demonstrated benefits in overall survival in the phase 3 DREAMM-7 trial.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaTech
NOVEMBER 23, 2024
The Thousand Oaks, Calif., cell therapy manufacturing facility now houses new production suites, updated development labs, and more after expansion.
Pharmacy Times
NOVEMBER 23, 2024
Data show that a child’s insurance status is independently associated with mortality after hematopoietic cell transplantation.
Expert insights. Personalized for you.
67 
Let's personalize your content